216 related articles for article (PubMed ID: 32079621)
1. The sarcoma diagnostic interval: a systematic review on length, contributing factors and patient outcomes.
Soomers V; Husson O; Young R; Desar I; Van der Graaf W
ESMO Open; 2020 Feb; 5(1):. PubMed ID: 32079621
[TBL] [Abstract][Full Text] [Related]
2.
Soomers V; Desar IM; van de Poll-Franse LV; Husson O; van der Graaf WT
BMJ Open; 2020 Oct; 10(10):e039309. PubMed ID: 33109665
[TBL] [Abstract][Full Text] [Related]
3. Prognostic significance of (18)F-FDG PET at diagnosis in patients with soft tissue sarcoma and bone sarcoma; systematic review and meta-analysis.
Kubo T; Furuta T; Johan MP; Ochi M
Eur J Cancer; 2016 May; 58():104-11. PubMed ID: 26990930
[TBL] [Abstract][Full Text] [Related]
4. Survival by histology among patients with bone and soft tissue sarcoma who undergo metastasectomy: protocol for a systematic review and meta-analysis.
Wang Y; Delisle M; Smith D; Srikanthan A
Syst Rev; 2020 Aug; 9(1):189. PubMed ID: 32819423
[TBL] [Abstract][Full Text] [Related]
5. Medical Care and Survival of Soft-Tissue and Bone Sarcoma Patients: Results and Methodological Aspects of a German Subnational Cohort Study Based on Administrative Healthcare Data.
Schoffer O; Roessler M; Datzmann T; Andreou D; Jakob J; Eichler M; Richter S; Schuler MK; Schmitt J
Oncol Res Treat; 2021; 44(3):103-110. PubMed ID: 33378758
[TBL] [Abstract][Full Text] [Related]
6. Enhancing Healthcare for Sarcoma Patients: Lessons from a Diagnostic Pathway Efficiency Analysis.
Elyes M; Heesen P; Schelling G; Bode-Lesniewska B; Studer G; Fuchs B;
Cancers (Basel); 2023 Oct; 15(19):. PubMed ID: 37835586
[TBL] [Abstract][Full Text] [Related]
7. Incidence, mortality, and survival trends of soft tissue and bone sarcoma in Switzerland between 1996 and 2015.
Kollár A; Rothermundt C; Klenke F; Bode B; Baumhoer D; Arndt V; Feller A;
Cancer Epidemiol; 2019 Dec; 63():101596. PubMed ID: 31520938
[TBL] [Abstract][Full Text] [Related]
8. Quality of life and patients' expectations in soft tissue sarcoma.
Jones RL; Cesne AL
Future Oncol; 2018 May; 14(10s):51-62. PubMed ID: 29768053
[TBL] [Abstract][Full Text] [Related]
9. Patient and diagnostic intervals of survivors of sarcoma: Results from the SURVSARC study.
Soomers VLMN; Husson O; Desar IME; van de Sande MAJ; de Haan JJ; Verhoef C; Vriens IJH; van Houdt WJ; van de Poll-Franse L; van der Graaf WTA
Cancer; 2020 Dec; 126(24):5283-5292. PubMed ID: 33002193
[TBL] [Abstract][Full Text] [Related]
10. The Perceived Impact of Length of the Diagnostic Pathway Is Associated with Health-Related Quality of Life of Sarcoma Survivors: Results from the Dutch Nationwide SURVSARC Study.
Soomers VLMN; Desar IME; van de Poll-Franse LV; van de Sande MAJ; de Haan JJ; Verhoef C; Vriens IJH; van Houdt WJ; Bonenkamp JJ; van der Graaf WTA; Husson O
Cancers (Basel); 2020 Jul; 12(8):. PubMed ID: 32731426
[TBL] [Abstract][Full Text] [Related]
11. The Patient Experience with Soft Tissue Sarcoma: A Systematic Review of the Literature.
Winnette R; Hess LM; Nicol SJ; Tai DF; Copley-Merriman C
Patient; 2017 Apr; 10(2):153-162. PubMed ID: 27744499
[TBL] [Abstract][Full Text] [Related]
12. Molecular analyses in the diagnosis and prediction of prognosis in non-GIST soft tissue sarcomas: A systematic review and meta-analysis.
Kandel RA; Yao X; Dickson BC; Ghert M; Popovic S; Purgina BM; Verma S; Werier J
Cancer Treat Rev; 2018 May; 66():74-81. PubMed ID: 29709714
[TBL] [Abstract][Full Text] [Related]
13. Outcome of Patients with Soft-Tissue Sarcomas: An Age-Specific Conditional Survival Analysis.
Bourcier K; Dinart D; Le Cesne A; Honoré C; Meeus P; Blay JY; Michot A; Le Loarer F; Italiano A
Oncologist; 2019 Jul; 24(7):e559-e564. PubMed ID: 31015315
[TBL] [Abstract][Full Text] [Related]
14. The symptom interval in children and adolescents with soft tissue sarcomas.
Ferrari A; Miceli R; Casanova M; Meazza C; Favini F; Luksch R; Catania S; Fiore M; Morosi C; Mariani L
Cancer; 2010 Jan; 116(1):177-83. PubMed ID: 19862818
[TBL] [Abstract][Full Text] [Related]
15. Relevance of Reference Centers in Sarcoma Care and Quality Item Evaluation: Results from the Prospective Registry of the Spanish Group for Research in Sarcoma (GEIS).
Martin-Broto J; Hindi N; Cruz J; Martinez-Trufero J; Valverde C; De Sande LM; Sala A; Bellido L; De Juan A; Rubió-Casadevall J; Diaz-Beveridge R; Cubedo R; Tendero O; Salinas D; Gracia I; Ramos R; Baguè S; Gutierrez A; Duran-Moreno J; Lopez-Pousa A
Oncologist; 2019 Jun; 24(6):e338-e346. PubMed ID: 30409793
[TBL] [Abstract][Full Text] [Related]
16. Age-related sarcoma patient experience: results from a national survey in England.
Younger E; Husson O; Bennister L; Whelan J; Wilson R; Roast A; Jones RL; van der Graaf WT
BMC Cancer; 2018 Oct; 18(1):991. PubMed ID: 30333006
[TBL] [Abstract][Full Text] [Related]
17. Soft tissue sarcoma in children: prognosis and management.
Koscielniak E; Morgan M; Treuner J
Paediatr Drugs; 2002; 4(1):21-8. PubMed ID: 11817983
[TBL] [Abstract][Full Text] [Related]
18. Semi-Quantitative Calculations of Primary Tumor Metabolic Activity Using F-18 FDG PET/CT as a Predictor of Survival in 92 Patients With High-Grade Bone or Soft Tissue Sarcoma.
Andersen KF; Fuglo HM; Rasmussen SH; Petersen MM; Loft A
Medicine (Baltimore); 2015 Jul; 94(28):e1142. PubMed ID: 26181552
[TBL] [Abstract][Full Text] [Related]
19. Does palliative chemotherapy really palliate and are we measuring it correctly? A mixed methods longitudinal study of health related quality of life in advanced soft tissue sarcoma.
Gough N; Koffman J; Ross JR; Riley J; Judson I
PLoS One; 2019; 14(9):e0210731. PubMed ID: 31557183
[TBL] [Abstract][Full Text] [Related]
20. Extremity soft tissue sarcoma with multiple primary malignancies--Characteristics and outcome.
Lopez-Oliva CL; Yun JY; Kim HS; Han I
Eur J Surg Oncol; 2016 Apr; 42(4):567-73. PubMed ID: 26873637
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
